期刊论文

中文

中国新药杂志

1003-3734

2009

18

24

2331-2336

10.3321/j.issn:1003-3734.2009.24.013

本校为其他机构

目的:研究双丹明目胶囊治疗糖尿病视网膜病变(单纯型)的临床疗效与安全性.方法:202例糖尿病视网膜病变(单纯型)患者随机分为双丹明目胶囊组(102例)和导升明组(100例),治疗16周.于治疗前、治疗后第8周、16周分别进行视力、视野、眼底荧光血管造影及糖尿病视网膜病变各项临床症状与体征变化检查.结果:两组治疗后患者眼科检查中的视网膜微血管瘤数目、出血、渗出、渗漏、毛细血管无灌注区面积、视野缺损区面积均有明显减少、视力明显提高.组间比较,治疗8周后、16周后眼科检查总分及微血管瘤计分、治疗16周后视力检查计分比较,差异有显著性意义(P

Objective: To investigate the efficacy and safe of Shuangdan Mingmu capsule in treating simple diabetic retinopathy. Methods: The diagnostic criteria of diabetic retinopathy were based on Diagnostics of Ophthal-mology and Practical Ophthalmology(published by Peoples Medical Publishing House). A total of 202 patients with diabetic retinopathy were randomly divided into two groups. They were treated with Shuangdan Mingmu capsule for 16 weeks ( n = 102) ,or with Daoshengming for 16 weeks ( n = 100). All the patients were inspected before treat-ment, and 8 and 16 weeks after treatment. The items o...